Table 27 (abstract P276). See text for description
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two
Treatment option | Clinical outcome | Systemic | RF+ polyarthritis | RF- polyarthritis | Oligoarthritis | ERA | PsA | UA |
|---|---|---|---|---|---|---|---|---|
MTX monotherapy | Active disease | 1 | 0 | 3 | 9 | 1 | 0 | 0 |
Remission on medication | 0 | 1 | 0 | 4 | 1 | 1 | 0 | |
Remission off medication | 1 | 1 | 0 | 2 | 1 | 1 | 1 | |
Biologics ±MTX | Active disease | 2 | 1 | 1 | 3 | 2 | 1 | 1 |
Remission on medication | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Remission off medication | 1 | 0 | 0 | 0 | 1 | 0 | 0 | |
No systemic medication/ only NSAIDs | Active disease | 0 | 0 | 0 | 0 | 2 | 0 | 0 |
Remission | 0 | 0 | 0 | 3 | 2 | 2 | 0 |